Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
---|---|---|---|---|---|---|---|---|
JNJ | JOHNSON & JOHNSON | United States | $364.06B | 2,406,679,183 | 68.67% | 0.19% | Net Selling | Net Selling |
SNY | SANOFI | France | $122.48B | 1,264,799,969 | 20.28% | 0.00% | ||
AZN | ASTRAZENECA PLC | United Kingdom | $239.07B | 1,550,162,626 | 31.27% | 0.00% | ||
LLY | ELI LILLY & CO | United States | $744.34B | 950,405,386 | 80.98% | 11.18% | Net Selling | Net Selling |
NVS | NOVARTIS AG | Switzerland | $209.83B | 2,040,400,000 | 6.85% | 0.00% | ||
GSK | GSK PLC | United Kingdom | $90.16B | 4,044,000,000 | 7.76% | 0.00% | ||
BIIB | BIOGEN INC | United States | $33.72B | 145,596,895 | 87.16% | 2.11% | Net Selling | Net Selling |
ABBV | ABBVIE INC | United States | $290.59B | 1,765,867,781 | 69.50% | 0.15% | Net Selling | Net Selling |
MRK | MERCK & CO INC | United States | $331.77B | 2,532,806,307 | 75.31% | 0.19% | Net Buying | Net Buying |
AMGN | AMGEN INC | United States | $168.73B | 536,434,692 | 75.31% | 1.01% | Net Selling | Net Selling |
GILD | GILEAD SCIENCES INC | United States | $84.59B | 1,245,853,209 | 81.78% | 1.09% | Net Selling | Net Selling |
BMY | BRISTOL MYERS SQUIBB CO | United States | $87.90B | 2,027,100,096 | 75.02% | 0.36% | Net Selling | Net Selling |
OGN | ORGANON & CO | United States | $5.60B | 257,170,727 | 76.68% | 0.20% | Net Selling | Net Selling |
GRFS | GRIFOLS SA | United States | $5.28B | 687,554,908 | 19.42% | 0.00% | ||
PFE | PFIZER INC | United States | $161.67B | 5,666,592,898 | 65.52% | 0.27% | Net Selling | Net Selling |
SCLX | SCILEX HOLDING CO | United States | $219.24M | 181,189,935 | 15.54% | 34.70% | Net Buying | Net Buying |
AMRN | AMARIN CORP PLC | Ireland | $361.56M | 410,868,659 | 21.49% | 15.40% | Net Selling | |
MIRA | MIRA PHARMACEUTICALS INC | United States | $12.56M | 14,780,885 | 3.77% | 30.26% | Net Buying |